Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 273 results found. Search for [ Remdesivir ]

Results 1 to 21 of 273
BusinessToday.In
New Delhi, November 21, 2020
COVID 19-driven reforms can raise India's medium-term growth; US President-elect Joe Biden has said he wants to make sure that China plays by the rules and announced that his administration will rejoin the World Health Organisation; Pfizer approaches USFDA to secure emergency use authorisation for COVID vaccine. Watch this and more news on News Blast.


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


Reuters
November 20, 2020
WHO suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients


Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


PB Jayakumar
November 18, 2020
Cipla will sell these kits across 25 markets in Asia, Middle-East and North Africa, Latin America, EU and Australia


Niti Kiran
November 17, 2020
\"The strong growth for Glenmark, Cipla and Cadila can be attributed to COVID-19-related products such as favipiravir, remdesivir and tocilizumab,\" said a Nomura report


BusinessToday.In
November 9, 2020
Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease


Reuters
November 9, 2020
Remdesivir was developed by US drugmaker Gilead Sciences, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of treatment


Chitranjan Kumar
November 6, 2020
Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


BusinessToday.In
October 26, 2020
Gold, Silver prices today: Gold, viewed as a hedge against inflation and currency debasement has risen over 25% this year, supported by unprecedented monetary stimulus from major central banks


BusinessToday.In
October 26, 2020
India Stock Market Highlights Today: Reliance Industries, followed by Tata Steel, Bajaj Finance, Asian Paints, M&M, ICICI Bank and Bajaj Finserv were among the top laggards in the Sensex pack today. On the other hand, IndusInd Bank, Nestle India, PowerGrid and L&T were among the gainers


PB Jayakumar
October 20, 2020
This drop in COVID-19 spread cases in India comes at a time when the virus is making a comeback in the US, the only country ahead of India in the case of total active cases


Chitranjan Kumar
October 20, 2020
The treatment of COVID-19 patients is expected to provide an additional revenue stream and contribute around 15-20 per cent to revenues this fiscal, says CRISIL report


BusinessToday.In
New Delhi, October 17, 2020
In a major respite to American aerospace company Boeing, Europe's top aviation regulator has declared its 737 MAX aircraft safe enough to return to skies; The World Bank and the International Monetary Fund said the global economic contraction caused by the ongoing coronavirus pandemic is the largest in the last eight decades; India could potentially scale up coronavirus testing ten-fold, said Biocon founder and Chairman Kiran Mazumdar-Shaw. Watch this and more on News Blast.Also Read: India to review COVID-19 treatment protocol after WHO report on remdesivir, HCQ


BusinessToday.In
October 17, 2020
India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients


BusinessToday.In
October 16, 2020
Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


BusinessToday.In
October 16, 2020
Coronavirus impact: The report said that the treatment could only partially improve the UK patient's impairment. It must be mentioned here that the \"rapid and unexplained\" deafness apparently only affects one ear


PAGES 1 OF 14  12345